BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 12656643)

  • 1. Clinical potential of insulin therapy in critically ill patients.
    Mesotten D; Van den Berghe G
    Drugs; 2003; 63(7):625-36. PubMed ID: 12656643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Insulin infusion for critically ill patients].
    Skeie S; Søreide E; Cooper J
    Tidsskr Nor Laegeforen; 2007 Sep; 127(18):2378-81. PubMed ID: 17895943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus recommendations for the management of hyperglycaemia in critically ill patients in the Indian setting.
    Mukherjee JJ; Chatterjee PS; Saikia M; Muruganathan A; Das AK;
    J Assoc Physicians India; 2014 Jul; 62(7 Suppl):16-25. PubMed ID: 25668933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive insulin therapy in critically ill patients.
    van den Berghe G; Wouters P; Weekers F; Verwaest C; Bruyninckx F; Schetz M; Vlasselaers D; Ferdinande P; Lauwers P; Bouillon R
    N Engl J Med; 2001 Nov; 345(19):1359-67. PubMed ID: 11794168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of intravenous insulin therapy in critically ill patients.
    Van den Berghe GH
    Endocr Pract; 2004; 10 Suppl 2():17-20. PubMed ID: 15251636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin therapy for the critically ill patient.
    Van den Berghe G
    Clin Cornerstone; 2003; 5(2):56-63. PubMed ID: 12800480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of the month. Toxicity of hyperglycemia in intensive care and beneficial effects of optimized insulin therapy].
    Scheen AJ
    Rev Med Liege; 2001 Dec; 56(12):859-61. PubMed ID: 11820041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose control in the intensive care unit.
    Fahy BG; Sheehy AM; Coursin DB
    Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study.
    Vlasselaers D; Milants I; Desmet L; Wouters PJ; Vanhorebeek I; van den Heuvel I; Mesotten D; Casaer MP; Meyfroidt G; Ingels C; Muller J; Van Cromphaut S; Schetz M; Van den Berghe G
    Lancet; 2009 Feb; 373(9663):547-56. PubMed ID: 19176240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond diabetes: saving lives with insulin in the ICU.
    Van den Berghe G
    Int J Obes Relat Metab Disord; 2002 Sep; 26 Suppl 3():S3-8. PubMed ID: 12174317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical benefits of tight glycaemic control: focus on the intensive care unit.
    Mesotten D; Van den Berghe G
    Best Pract Res Clin Anaesthesiol; 2009 Dec; 23(4):421-9. PubMed ID: 20108581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.
    Van den Berghe G; Wouters PJ; Bouillon R; Weekers F; Verwaest C; Schetz M; Vlasselaers D; Ferdinande P; Lauwers P
    Crit Care Med; 2003 Feb; 31(2):359-66. PubMed ID: 12576937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperglycemia in critically ill patients: clinical implications for treatment].
    Miranda-Ruiz R; Castañón-González JA
    Cir Cir; 2004; 72(6):517-24. PubMed ID: 15694061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The glucoregulatory benefits of glucagon-like peptide-1 (7-36) amide infusion during intensive insulin therapy in critically ill surgical patients: a pilot study.
    Galiatsatos P; Gibson BR; Rabiee A; Carlson O; Egan JM; Shannon RP; Andersen DK; Elahi D
    Crit Care Med; 2014 Mar; 42(3):638-45. PubMed ID: 24247476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial.
    Ritsinger V; Malmberg K; Mårtensson A; Rydén L; Wedel H; Norhammar A
    Lancet Diabetes Endocrinol; 2014 Aug; 2(8):627-33. PubMed ID: 24831989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic control in the medical intensive care unit.
    Kovalaske MA; Gandhi GY
    J Diabetes Sci Technol; 2009 Nov; 3(6):1330-41. PubMed ID: 20144387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive insulin therapy in the medical ICU.
    Van den Berghe G; Wilmer A; Hermans G; Meersseman W; Wouters PJ; Milants I; Van Wijngaerden E; Bobbaers H; Bouillon R
    N Engl J Med; 2006 Feb; 354(5):449-61. PubMed ID: 16452557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control.
    Robinson LE; van Soeren MH
    AACN Clin Issues; 2004; 15(1):45-62. PubMed ID: 14767364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms behind clinical benefits of intensive insulin therapy during critical illness: glucose versus insulin.
    Vanhorebeek I; Langouche L
    Best Pract Res Clin Anaesthesiol; 2009 Dec; 23(4):449-59. PubMed ID: 20108584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin therapy in critically ill patients.
    Solano T; Totaro R
    Curr Opin Clin Nutr Metab Care; 2004 Mar; 7(2):199-205. PubMed ID: 15075712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.